AVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.37), $0.12 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $10.55 million versus the consensus estimate of $10.35 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.